SCHEMBL22316563

SCHEMBL22316563

CC(C)N[C@H](CCC(=O)O)C(=O)OC(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSK P43235 1/20 0.38
FOLH1 Q04609 9/20 0.38
NAALAD2 Q9Y3Q0 2/20 0.38
RIMKLA Q8IXN7 1/20 0.38
GABRP O00591 2/20 0.37
GABRD O14764 2/20 0.37
GABRA1 P14867 2/20 0.37
GABRB1 P18505 2/20 0.37
GABRG2 P18507 2/20 0.37
GABRB3 P28472 2/20 0.37
GABRA5 P31644 2/20 0.37
GABRA3 P34903 2/20 0.37
GABRA2 P47869 2/20 0.37
GABRB2 P47870 2/20 0.37
GABRA4 P48169 2/20 0.37
GABRE P78334 2/20 0.37
GABRA6 Q16445 2/20 0.37
GABRG1 Q8N1C3 2/20 0.37
GABRG3 Q99928 2/20 0.37
GABRQ Q9UN88 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4750877 0.87 FOLH1 (0.38) CTSKFOLH1NAALAD2RIMKLAGABRP
SCHEMBL25453631 0.87 CTSK (0.41) CTSKCYP1A2MEN1GAAKMT2A
SCHEMBL12267040 0.83 ANPEP (0.42) FOLH1NAALAD2RIMKLAGABRPGABRD
SCHEMBL22316568 0.83 ANPEP (0.42) FOLH1NAALAD2RIMKLAGABRPGABRD
SCHEMBL5172322 0.83 ANPEP (0.42) FOLH1NAALAD2RIMKLAGABRPGABRD
SCHEMBL29340198 0.81 CTSK (0.35) CTSK
SCHEMBL13863589 0.81 FOLH1 (0.39) FOLH1NAALAD2RIMKLAGABRPGABRD
SCHEMBL4363123 0.81 FOLH1 (0.43) CTSKFOLH1NAALAD2RIMKLACYP1A2
SCHEMBL8328113 0.81 CTSK (0.39) CTSKCYP1A2MEN1GAAKMT2A
SCHEMBL12626915 0.81 FOLH1 (0.43) CTSKFOLH1NAALAD2RIMKLACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same Sumitomo Pharma Co., Ltd. (JP) 2024-06-25 US disclosed
US-20200247845-A1 Hemiasterlin Derivatives and Antibody-Drug Conjugates Including Same SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200247845-A1 Hemiasterlin Derivatives and Antibody-Drug Conjugates Including Same FCGRT, QARS1, INHA CTSK 3432/4885FOLH1 4072/4885NAALAD2 984/4885
US-12018093-B2 Hemiasterlin derivatives and antibody-drug conjugates including same FCGRT, QARS1, INHA CTSK 3432/4885FOLH1 4072/4885NAALAD2 984/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.